- Tumor Specific PET Probes
- Positron Emission Tomography (PET)
- PET-Based Tumor Imaging
Board Certification and Academic Information
||Radiology - Professor
||American Board of Nuclear Medicine (Nuc Med)
American Board of Radiology (Diagnostic Radiology)
National Board of Medical Examiners
|Cancer Center Programs
Academic Office Locations
|Academic Office Phone Number
||Academic Office Address
||School of Medicine
30 N 1900 E
Salt Lake City, UT 84132
Kathryn Morton, MD, is a professor in the Department of Radiology at the University of Utah School of Medicine. She is an investigator at the Huntsman Cancer Institute and a member of the Experimental Therapeutics program. Her research interests include PET-based tumor imaging and tumor-specific PET probes.
Dr. Morton’s work has explored the use of PET/CT imaging to screen at-risk patients (unprovoked venous thromboembolism) for early or hidden cancers. She has also examined the use of PET/CT as an improved protocol for staging head and neck cancer patients, and has worked to improve the use of PET for radiologic diagnosis of brain cancer. Dr. Morton’s research has also included the development and use of new neuroimaging modalities and probes for the study of neurodegenerative diseases, and she has worked on the use of PET for early diagnosis of acute respiratory distress syndrome and for evaluation of deep vein thrombosis.
Morton received her medical degree from the University of Utah, followed by an internship in Pediatrics at the University of North Carolina at Chapel Hill and residencies in Radiology and Nuclear Medicine at the University of Utah.